TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Hisamitsu Pharmaceutical Co ( (JP:4530) ) has issued an update.
Hisamitsu Pharmaceutical Co., Inc. announced the acquisition of 392,000 of its own shares, totaling approximately 1.67 billion yen, through open market purchases on the Tokyo Stock Exchange during September 2025. This move is part of a broader strategy approved by the board to acquire up to 3 million shares by the end of 2025, aiming to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:4530) stock is a Hold with a Yen4447.00 price target. To see the full list of analyst forecasts on Hisamitsu Pharmaceutical Co stock, see the JP:4530 Stock Forecast page.
More about Hisamitsu Pharmaceutical Co
Hisamitsu Pharmaceutical Co., Inc. is a company based in Tosu City, Saga Prefecture, Japan. It operates in the pharmaceutical industry, focusing on the development and sale of healthcare products, including transdermal patches and other medical treatments.
Average Trading Volume: 193,480
Technical Sentiment Signal: Sell
Current Market Cap: Yen297.6B
Find detailed analytics on 4530 stock on TipRanks’ Stock Analysis page.